Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10354880Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2024
Linked Award Amount
$688K
Full award amounts, FY2024
Award Records
1
Records listing this PI
Award-Linked Rank
#22,646
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Marcin Kortylewski as a PI. Multi-PI records show the full award amount for context.
- 5R01CA284593-02R01Myeloid cell-selective, oligonucleotide-based STAT3 inhibition combined with total marrow and lymphoid irradiation for immunotherapy of acute myeloid leukemia$688Kaward amount
Award organization
Organizations that administered FY2024 awards listing Marcin Kortylewski as a PI.
FY2024 award administered by Beckman Research Institute/City of Hope (CA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardBeckman Research Institute/City of Hope
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2025R01 Grant Holder
- 2026$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Marcin Kortylewski.